From the Exalgo website in the hypothetical patient profile for Dennis under the Dose Conversion tab. Its tagline is "EXALGO could give Dennis the pain relief he wants - with a once-daily dose." It includes survey results with a bar graph from a double-blind placebo-controlled withdrawal study of opioid-tolerant patients with low back pain. That study claims that median pain intensity scores were 8 times higher for the placebo group (1.6 change from baseline) vs. the Exalgo group (0.2 change from baseline). There is also Important Risk Information.
The background is blue and white with text in black and white and 5 graphic elements (4 black and white portrait photographs and 1 silhouette of a man walking his dog). Two menu bars are at the top of the page and one menu bar is at the bottom of the page. The Exalgo logo is in the bottom right corner.
Description 
Type
Category
Source 1 of 2
-
Date
2011
Collection
-
Date
2011
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
